Uncoupling of hepatic, epidermal growth factor-mediated mitogen-activated protein kinase activation in the fetal rat

J M Boylan1, P A Gruppuso

  • 1Department of Pediatrics, Division of Pediatric Endocrinology and Metabolism, Rhode Island Hospital and Brown University, Providence, Rhode Island 02903, USA.

Insights

Developing rat liver cells show a unique feedback mechanism that prevents full activation of the mitogen-activated protein (MAP) kinase pathway. This pathway is crucial for cell proliferation and is regulated differently in fetal versus adult rats.

Area of Science:

  • Cell signaling and proliferation
  • Developmental biology
  • Molecular endocrinology

Background:

  • Mitogen-activated protein (MAP) kinase pathway activation is essential for cell proliferation, initiated by receptor tyrosine kinases and involving proteins like Ras, Raf, and MEK.
  • Previous research indicated epidermal growth factor (EGF) rapidly activates hepatic MAP kinases in adult rats but not in late gestation fetal rats.
  • This suggests an 'uncoupling' of the MAP kinase pathway in fetal development.

Purpose of the Study:

  • To investigate the mechanism behind the uncoupling of the MAP kinase pathway in late gestation fetal rats compared to adult rats.
  • To understand the developmental acquisition of intact MAP kinase signaling in rat hepatocytes.

Main Methods:

  • Intraperitoneal injection of EGF or saline into E19 fetal and adult male rats, followed by liver kinase analysis.
  • Western immunoblotting to determine MAP kinase content during postnatal development.
  • In vitro recombination experiments with partially purified MEK and MAP kinase from fetal and adult rat livers.
  • Primary culture of E19 fetal rat hepatocytes treated with transforming growth factor-alpha.

Main Results:

  • EGF injection activated Raf and MEK in both fetal and adult rats, but MAP kinase activation was minimal in fetuses.
  • Intact MAP kinase signaling was gradually acquired during the first four postnatal weeks, with constant MAP kinase content.
  • In vitro experiments showed intact MAP kinase activation, suggesting no irreversible enzyme alterations in the fetus.
  • Transforming growth factor-alpha induced uncoupling in fetal hepatocytes, indicating a potential negative feedback mechanism.

Conclusions:

  • A novel negative feedback mechanism for MAP kinase regulation appears to be active in developing rat hepatocytes.
  • This mechanism prevents full MAP kinase activation in fetal liver cells, despite upstream pathway activation.
  • The findings highlight a critical developmental regulation of cell proliferation signaling.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...